Your browser doesn't support javascript.
loading
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.
Shin, Hwang Sik; Jun, Baek Gyu; Yi, Sang-Wook.
Afiliação
  • Shin HS; Department of Family Medicine, Soonchunhyang University Hospital Cheonan, Soonchunhyang University College of Medicine, Cheonan, Korea.
  • Jun BG; Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  • Yi SW; Department of Preventive Medicine and Public Health, College of Medicine, Catholic Kwandong University, Gangneung, Korea.
Clin Mol Hepatol ; 28(4): 773-789, 2022 10.
Article em En | MEDLINE | ID: mdl-35934813

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus / Dislipidemias / Hepatopatia Gordurosa não Alcoólica / Hepatopatias Alcoólicas / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Inibidores de Hidroximetilglutaril-CoA Redutases / Diabetes Mellitus / Dislipidemias / Hepatopatia Gordurosa não Alcoólica / Hepatopatias Alcoólicas / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article